BASAL CELL CARCINOMA
Clinical trials for BASAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BASAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for BASAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Imaging-Guided laser zaps skin cancer, aims to avoid surgery
Disease control OngoingThis study is testing a laser treatment for basal cell carcinoma, a common type of skin cancer. Doctors use a special imaging tool called OCT to see the cancer's exact size and depth, then guide the laser to target it precisely. The goal is to effectively remove the cancer while …
Matched conditions: BASAL CELL CARCINOMA
Phase: NA • Sponsor: Christopher Zachary • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists test new 'In-Situ' cancer vaccine strategy
Disease control OngoingThis early-stage trial is testing the safety of a new combination treatment for people with advanced cancers that have spread and cannot be removed by surgery. Doctors inject immune-stimulating drugs directly into a tumor, then give a small dose of radiation to that same spot. Th…
Matched conditions: BASAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis large national trial is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control over 50 different types of rare cancers that have few or no standard treatment options. It enrolled over 800 adults whose rare cancers had progressed …
Matched conditions: BASAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New injection aims to shrink skin cancer tumors before removal
Disease control OngoingThis study is testing an experimental drug called BO-112, which is injected directly into basal cell carcinoma skin cancer tumors. The goal is to see if the injection can shrink or eliminate the tumors before they are surgically removed, and to check how safe it is. The trial wil…
Matched conditions: BASAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Highlight Therapeutics • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
Scientists watch skin cancer grow for 3 years to find better ways to monitor it
Knowledge-focused OngoingThis study aims to learn more about how basal cell carcinoma (BCC), a common type of skin cancer, grows over time. It will not provide any treatment to participants. Instead, researchers will closely monitor small, untreated BCCs in 26 adults for three years using special imaging…
Matched conditions: BASAL CELL CARCINOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC